1. Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study. (2nd November 2017) Authors: Lindqvist, U; Gudbjornsson, B; Iversen, L; Laasonen, L; Ejstrup, L; Ternowitz, T; Ståhle, M Journal: Scandinavian journal of rheumatology Issue: Volume 46:Number 6(2017) Page Start: 454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hyaluronan concentration and molecular mass in psoriatic arthritis: biomarkers of disease severity, resistance to treatment, and outcome. (4th July 2019) Authors: Hellman, U; Engström-Laurent, A; Larsson, A; Lindqvist, U Journal: Scandinavian journal of rheumatology Issue: Volume 48:Number 4(2019) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Psoriatic arthritis mutilans (PAM) in the Nordic countries: demographics and disease status. The Nordic PAM study. (October 2013) Authors: Gudbjornsson, B; Ejstrup, L; Gran, JT; Iversen, L; Lindqvist, U; Paimela, L; Ternowitz, T; Ståhle, M Journal: Scandinavian journal of rheumatology Issue: Volume 42:Number 5(2013) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Up-regulation of CD64-expressing monocytes with impaired FcγR function reflects disease activity in polyarticular psoriatic arthritis. (2nd November 2015) Authors: Matt, P; Lindqvist, U; Kleinau, S Journal: Scandinavian journal of rheumatology Issue: Volume 44:Number 6(2015) Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗